Ingrid Kleber

438 total citations
26 papers, 387 citations indexed

About

Ingrid Kleber is a scholar working on Molecular Biology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Ingrid Kleber has authored 26 papers receiving a total of 387 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Molecular Medicine and 8 papers in Pharmacology. Recurrent topics in Ingrid Kleber's work include Antibiotic Resistance in Bacteria (9 papers), Bacteriophages and microbial interactions (8 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Ingrid Kleber is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Bacteriophages and microbial interactions (8 papers) and Antibiotics Pharmacokinetics and Efficacy (8 papers). Ingrid Kleber collaborates with scholars based in Germany and United States. Ingrid Kleber's co-authors include Walter H. Traub, Rolf Benzinger, Georg Acker, Robert J. Huskey, W. David Henner, Volker Brade, Charles E. Mitchell, Larry Lawhorne, Alfred Pühler and F. Zilliken and has published in prestigious journals such as Journal of Virology, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Ingrid Kleber

25 papers receiving 324 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ingrid Kleber Germany 11 195 78 70 67 55 26 387
E Blackman United States 10 202 1.0× 63 0.8× 97 1.4× 168 2.5× 134 2.4× 12 747
B L Angus Canada 5 233 1.2× 63 0.8× 34 0.5× 140 2.1× 168 3.1× 7 409
Paul Balbo United States 9 278 1.4× 77 1.0× 110 1.6× 107 1.6× 44 0.8× 11 549
Michael J. Fiske United States 13 282 1.4× 42 0.5× 34 0.5× 34 0.5× 24 0.4× 14 470
I. Haller Germany 10 168 0.9× 75 1.0× 67 1.0× 126 1.9× 78 1.4× 24 388
Corinne Fayolle France 9 320 1.6× 60 0.8× 45 0.6× 285 4.3× 70 1.3× 10 547
Edwige Madec France 14 330 1.7× 111 1.4× 72 1.0× 220 3.3× 37 0.7× 18 542
L F Guymon United States 10 134 0.7× 27 0.3× 56 0.8× 77 1.1× 67 1.2× 11 509
Robert Kajioka Canada 8 108 0.6× 73 0.9× 88 1.3× 95 1.4× 34 0.6× 10 506
Susan Puckett United States 8 255 1.3× 100 1.3× 128 1.8× 56 0.8× 49 0.9× 9 396

Countries citing papers authored by Ingrid Kleber

Since Specialization
Citations

This map shows the geographic impact of Ingrid Kleber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Kleber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Kleber more than expected).

Fields of papers citing papers by Ingrid Kleber

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ingrid Kleber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Kleber. The network helps show where Ingrid Kleber may publish in the future.

Co-authorship network of co-authors of Ingrid Kleber

This figure shows the co-authorship network connecting the top 25 collaborators of Ingrid Kleber. A scholar is included among the top collaborators of Ingrid Kleber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ingrid Kleber. Ingrid Kleber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brade, Volker, Ingrid Kleber, & Georg Acker. (1992). Differences of two Borrelia burgdorferi strains in complement activation and serum resistance. Immunobiology. 185(5). 453–465. 52 indexed citations
2.
Kleber, Ingrid, et al.. (1978). Serotyping of Serratia marcescens: determination of serogroup (O) antigens and serological cross-reactions.. PubMed. 240(1). 30–56. 10 indexed citations
3.
Benzinger, Rolf, Ingrid Kleber, & Robert J. Huskey. (1978). Transfection of Escherichia coli Spheroplasts: Infectious Lambda Prophage DNA. Journal of General Virology. 39(3). 531–535. 3 indexed citations
4.
Traub, Walter H. & Ingrid Kleber. (1977). Inactivation of classical and alternative pathway-activated bactericidal activity of human serum by sodium polyanetholsulfonate. Journal of Clinical Microbiology. 5(3). 278–284. 17 indexed citations
5.
Traub, Walter H. & Ingrid Kleber. (1977). Serotyping of Serratia marcescens: evaluation of Le Minor's H-immobilization test and description of three new flagellar H antigens. Journal of Clinical Microbiology. 5(2). 115–121. 28 indexed citations
6.
7.
Traub, Walter H., Georg Acker, & Ingrid Kleber. (1976). Ultrastructural Surface Alterations of <i>Serratia marcescens</i> after Exposure to Polymyxin B and/or Fresh Human Serum. Chemotherapy. 22(2). 104–113. 18 indexed citations
8.
Traub, Walter H., et al.. (1976). Characterization of a Nosocomially Significant, Multiple Drug-Resistant Strain of <i>Serratia marcescen</i><i>s</i>. Chemotherapy. 22(5). 297–312. 8 indexed citations
9.
Traub, Walter H. & Ingrid Kleber. (1975). Studies on the Additive Effect of Polymyxin B and the Bactericidal Activity of Human Serum against <i>Serratia marcescen</i><i>s</i>. Chemotherapy. 21(3-4). 189–204. 15 indexed citations
10.
Traub, Walter H. & Ingrid Kleber. (1975). Characterization of Two H<sub>2</sub>S Producing, Multiple Drug-Resistant Isolates of <i>Escherichia coli</i>from Clinical Urine Specimens. Pathobiology. 43(1). 10–16. 3 indexed citations
11.
Traub, Walter H. & Ingrid Kleber. (1975). In Vitro Additive Effect of Polymyxin B and Rifampin Against Serratia marcescens. Antimicrobial Agents and Chemotherapy. 7(6). 874–876. 17 indexed citations
12.
Acker, G, et al.. (1974). Studies on phage tail bacteriocins of Proteus rettgeri.. PubMed. 229(3). 362–71. 1 indexed citations
13.
Traub, Walter H. & Ingrid Kleber. (1974). Detection of Fibrinolytic and Elastase Activity Among Clinical Isolates of <i>Serratia Marcescen</i><i>s</i>. Pathobiology. 41(6). 334–340. 7 indexed citations
14.
Kleber, Ingrid, et al.. (1974). Continued epidemiological surveillance of Serratia marcescens infections by bacteriocin typing, with particular reference to strains isolated at Erlangen.. PubMed. 229(3). 372–82. 4 indexed citations
15.
Kleber, Ingrid, et al.. (1974). Isolation of two strains of Klebsiella pneumoniae with transferable resistance determinants against ten antimicrobial drugs from clinical material.. PubMed. 229(1). 80–8. 3 indexed citations
16.
Kleber, Ingrid, et al.. (1974). Studies on group A (phage tail) bacteriocins of Serratia marcescens. IV. Preliminary characterization of receptors of subgroup II bacteriocins.. PubMed. 229(4). 490–502. 3 indexed citations
17.
18.
Traub, Walter H., et al.. (1973). Induction of Group A Bacteriocins of Serratia marcescens by Nalidixic Acid. Nature New Biology. 245(144). 144–145. 4 indexed citations
19.
Lawhorne, Larry, Ingrid Kleber, Charles E. Mitchell, & Rolf Benzinger. (1973). Transfection of Escherichia coli Spheroplasts II. Relative Infectivity of Native, Denatured, and Renatured Lambda, T7, T5, T4, and P22 Bacteriophage DNAs. Journal of Virology. 12(4). 733–740. 14 indexed citations
20.
Benzinger, Rolf, Ingrid Kleber, & Robert J. Huskey. (1971). Transfection of Escherichia coli Spheroplasts I. General Facilitation of Double-Stranded Deoxyribonucleic Acid Infectivity by Protamine Sulfate. Journal of Virology. 7(5). 646–650. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Blackman Breakdown of academic impact, for papers by B L Angus Breakdown of academic impact, for papers by Paul Balbo Breakdown of academic impact, for papers by Michael J. Fiske Breakdown of academic impact, for papers by I. Haller Breakdown of academic impact, for papers by Corinne Fayolle Breakdown of academic impact, for papers by Edwige Madec Breakdown of academic impact, for papers by L F Guymon Breakdown of academic impact, for papers by Robert Kajioka Breakdown of academic impact, for papers by Susan Puckett
Rankless by CCL
2026